Price (delayed)

$33.75

Market cap

$1.5B

P/E Ratio

N/A

Dividend/share

$0.28

EPS

-$2.27

Enterprise value

$1.82B

CLB's debt is down by 11% YoY and by 6% from the previous quarter

CLB's equity has plunged by 64% YoY but it is up by 9% from the previous quarter

Core Laboratories N V's EPS has plunged by 200% YoY and by 26% from the previous quarter

The quick ratio has shrunk by 54% YoY and by 53% QoQ

What are the main financial stats of CLB

Market
Valuations
Earnings

Shares outstanding

44.49M

Market cap

$1.5B

Enterprise value

$1.82B

Price to earnings (P/E)

N/A

Price to book (P/B)

22.2

Price to sales (P/S)

2.83

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.43

Revenue

$530.3M

EBIT

-$79.27M

EBITDA

-$57.71M

Free cash flow

$78.18M

Per share
Balance sheet
Liquidity

EPS

-$2.27

Free cash flow per share

$1.76

Book value per share

$1.52

Revenue per share

$11.92

TBVPS

$10.85

Total assets

$590.81M

Total liabilities

$519.11M

Debt

$333.02M

Equity

$67.63M

Working capital

-$2.25M

Debt to equity

4.92

Current ratio

0.99

Quick ratio

0.58

Net debt/EBITDA

-5.51

Margins
Efficiency
Dividend

EBITDA margin

-10.9%

Gross margin

23.7%

Net margin

-19%

Operating margin

-14.9%

Return on assets

-15.4%

Return on equity

-108.1%

Return on invested capital

-10.7%

Return on capital employed

-18.9%

Return on sales

-14.9%

Dividend yield

0.83%

DPS

$0.28

Payout ratio

N/A

How has the Core Laboratories N V stock price performed over time

Intraday

-4.82%

1 week

8.94%

1 month

17.6%

1 year

-15.35%

YTD

27.31%

QTD

27.31%

How have Core Laboratories N V's revenue and profit performed over time

Revenue

$530.3M

Gross profit

$125.7M

Operating income

-$79.15M

Net income

-$100.84M

Gross margin

23.7%

Net margin

-19%

Core Laboratories N V's operating income has shrunk by 185% YoY and by 34% QoQ

The operating margin has plunged by 51% from the previous quarter

CLB's net margin is down by 42% from the previous quarter

CLB's gross profit is down by 31% year-on-year and by 15% since the previous quarter

What is Core Laboratories N V's growth rate over time

What is Core Laboratories N V stock price valuation

P/E

N/A

P/B

22.2

P/S

2.83

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.43

Core Laboratories N V's EPS has plunged by 200% YoY and by 26% from the previous quarter

The P/B is 118% above the last 4 quarters average of 10.2 but 6% below the 5-year quarterly average of 23.6

CLB's equity has plunged by 64% YoY but it is up by 9% from the previous quarter

CLB's price to sales (P/S) is 89% higher than its last 4 quarters average of 1.5 but 49% lower than its 5-year quarterly average of 5.5

The company's revenue fell by 23% YoY and by 11% QoQ

How efficient is Core Laboratories N V business performance

The return on invested capital has dropped by 178% year-on-year and by 41% since the previous quarter

The return on equity has dropped by 67% since the previous quarter

Core Laboratories N V's ROS has decreased by 49% from the previous quarter

The ROA has contracted by 36% from the previous quarter

What is CLB's dividend history

DPS

$0.28

Dividend yield

0.83%

Payout ratio

N/A

Recent dividends

How did Core Laboratories N V financials performed over time

The total assets is 14% greater than the total liabilities

The quick ratio has shrunk by 54% YoY and by 53% QoQ

CLB's current ratio is down by 49% since the previous quarter and by 48% year-on-year

The debt to equity has soared by 151% YoY but it has decreased by 14% QoQ

CLB's equity has plunged by 64% YoY but it is up by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.